News
-
-
PRESS RELEASE
Next Gen Diagnostics Announces New York State Department of Health’s Wadsworth Center Has Joined the NGD Cefiderocol Data Consortium for the Sequencing-Based Determination of Cefiderocol Resistance
NGD and Wadsworth Center announce collaboration to develop WGS-based cefiderocol prediction for bacterial resistance to antibiotics, aiming to combat carbapenem-resistant infections -
-
PRESS RELEASE
Next Gen Diagnostics Announces Agreement to Develop Sequence-Based Susceptibility Determination of Cefiderocol
Next Gen Diagnostics partners with Shionogi to develop whole genome sequence-based models for cefiderocol susceptibility in Gram-negative bacteria, enhancing antibiotic testing -
-
PRESS RELEASE
Dr. Alexander Sundermann Joins Next Gen Diagnostics as Its Director of Infection Prevention Services
Next Gen Diagnostics appoints Dr. Alexander Sundermann of University of Pittsburgh School of Public Health as Director of Infection Prevention Services. Dr. Sundermann is a key figure in prospective sequencing for infection detection -
-
PRESS RELEASE
Next Gen Diagnostics Announces Opening of a US Sequencing and Bioinformatics Laboratory in Cambridge, Massachusetts
Next Gen Diagnostics announces the opening of its first US laboratory in Cambridge, MA, offering low-cost bacterial sequencing and bioinformatics services. The company leverages advanced technologies for high throughput and cost-effective analysis -
-
PRESS RELEASE
Next Gen Diagnostics CEO Paul Rhodes Announces That Dr. Linoj Samuel Has Joined NGD’s Scientific Advisory Board
Next Gen Diagnostics announces addition of Dr. Linoj Samuel, a national leader in clinical microbiology, to its Scientific Advisory Board. Dr. Samuel will provide insights on leveraging WGS in clinical practice
